Navigation Links
Georgia State researcher gets $499,209 NSF grant to advance sociogenomics
Date:9/24/2013

Dr. Walter Wilczynski in the Center for Behavioral Neuroscience at Georgia State University has received a five-year $499,209 National Science Foundation grant to form a Research Coordination Network focused on advancing the field of sociogenomics.

This field can be the foundation for integrating molecular biology, neuroscience, psychology and evolutionary biology to provide deep insights into the molecular processes behind social interactions in all species, including humans.

Sociogenomics is an emerging field of biology. It is dedicated to identifying genes that influence social behavior and how these genes affect neural circuits in the brain. It also examines ways in which the social environment influences how an individual's genes are expressed. According to Wilczynski, understanding the root of social behavior at the molecular level is a high-stakes endeavor with important conceptual and biomedical implications.

"This knowledge has the potential to impact mechanistic and evolutionary questions in basic biological science by providing deep insights into the genetic mechanisms responsible for behaviors as diverse as social bonding, cooperation and aggression that are common in many organisms including humans and how these have evolved," said Wilczynski, who is also director of Georgia State's Neuroscience Institute and a professor of neuroscience and psychology.

"Sociogenomics also has important medical implications. Many neurological disorders from autism spectrum disorders to schizophrenia can severely impair a person's ability to engage in normal social interactions. Understanding how social behavior is regulated at the molecular level will help us understand these diseases."

This grant is part of the National Science Foundation's Research Coordination Network grant program, which funds activities to advance a field or create new directions in research or education by supporting groups of investigators to communicate and coordinate their research.

Wilczynski's network, known as the Sociogenomics Initiative RCN, will bring together researchers, faculty and students from several prominent universities across the U.S. and Canada who are focused on the genomic mechanisms underlying social behavior. Other institutions represented are: Colorado State University, Columbia University, Cornell University, Duke University, Emory University, Georgia Institute of Technology, Harvard University, Hutchinson Research Center, Johns Hopkins University, Indiana University, Iowa State University, Morehouse College, North Carolina State University, Penn State University, Stanford University, the University of Illinois, the University of Texas, the University of Toronto and the University of Virginia.

"Developing comprehensive knowledge of social behavior in molecular terms requires large-scale collaboration and multidisciplinary approaches," Wilczynski said. "Additionally, sustaining progress in this complex area of biology requires integrating the research with student training. Ongoing structured interaction among network members will provide the scale and analytical power necessary to achieve a transformation in the understanding of social behavior's molecular basis."

The network's goals are to establish and sustain a consortium of researchers who will advance the field of sociogenomics through collaborations, data sharing and technical development. Another is to extend interest in sociogenomics to a broader range of researchers in numerous fields. The third is to link the network's research functions to educational initiatives. These goals will be accomplished through cohesive activities such as hosting an annual sociogenomics international meeting, supporting exchanges between labs, conducting workshops and maintaining a network website.


'/>"/>

Contact: Natasha De Veauuse Brown, M.P.H.
ndeveauusebrown@gsu.edu
404-413-3602
Georgia State University
Source:Eurekalert

Related biology news :

1. Georgia Physicians Study Published in The Journal of Urology
2. Emory, Georgia Tech receive first human exposome center grant in US
3. Georgia State University research finds Clean Air Act increased Atlanta rainfall
4. Marshall University study may lead to new treatments for prostate cancer
5. Interventional radiology: Potential breakthrough to treat mens enlarged prostate
6. Carnegies Greg Asner named Energy/Climate Fellow by US State Department
7. Planet under Pressure conference, London: Final statement
8. Tokai Pharmaceuticals galeterone well-tolerated in patients with advanced prostate cancer
9. NRC authors brief federal agencies on the state of polar regions
10. Study shows botanical formula fights prostate cancer
11. Ohio state hosts national energy conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2016)... Calif. , Feb. 2, 2016  Based ... market, Frost & Sullivan recognizes US-based Intelligent Retinal ... Frost & Sullivan Award for New Product Innovation. ... in North America , is ... the rapidly growing diabetic retinopathy market. The IRIS ...
(Date:1/28/2016)... Jan. 28, 2016 Synaptics (NASDAQ: SYNA ), a ... its second quarter ended December 31, 2015. ... of fiscal 2016 increased 2 percent compared to the comparable quarter ... of fiscal 2016 was $35.0 million, or $0.93 per diluted share. ... income for the first quarter of fiscal 2016 grew 9 percent ...
(Date:1/22/2016)... DUBLIN , January 22, 2016 ... has announced the addition of the  ... to their offering. --> ... of the  "Global Behavioral Biometric Market ... --> Research and Markets ( http://www.researchandmarkets.com/research/4lmf2s/global_behavioral ...
Breaking Biology News(10 mins):
(Date:2/4/2016)... China , Feb. 4, 2016 Beike ... and various medical institutions attended a ceremony in late ... integrative, personalized cell therapy in 2016. ... "Shenzhen Clinical Translation Platform for Personalized Cell Therapy" was ... Regional Cell Production Center, both subsidiaries of Beike Biotechnology ...
(Date:2/4/2016)... and MENLO PARK, Calif. , Feb. 4, ... and the "Company"), a biopharmaceutical company focused on the development ... will present at the 18 th Annual BIO ... at 10:00 a.m. EST in New York, NY ... and CEO, will provide an update on the ongoing clinical ...
(Date:2/4/2016)... Feb. 4, 2016 ContraVir Pharmaceuticals, Inc. (NASDAQ: ... development and commercialization of targeted antiviral therapies, announced today ... Conference 2016, to be held February 8-9, 2016, at ... 2016 Disruptive Growth & Healthcare Conference, taking place in ... 2016. James Sapirstein , Chief Executive Officer ...
(Date:2/4/2016)... BEIJING , Feb. 4, 2016 Sinovac ... ), a leading provider of biopharmaceutical products in ... committee of its board of directors received on February ... 3, 2016, from a consortium comprised of PKU V-Ming ... Sinobioway Biomedicine Co., Ltd., CICC Qianhai Development ( ...
Breaking Biology Technology: